Prolytic

Prolytic GmbH as part of the KYMOS group is a CRO in the fields of bioanalyses and pharmacokinetics . All analytical services can be performed under GLP and GCP. Prolytic develops analytical assays for determination of substances in different matrices (plasma, urine, tissue and a l ot more) validates methods according to FDA and ICH Guidelines quickly and reliable. We support our customers during preclinical, clinical, ADME-Tox or biomarker studies. Our services: Small molecules - LC-MS/MS Biomarker - LC-MS/MS, ELISA, qPCR Formulation - HPLC Large molecules - ELISA Antibodies - ELISA Antigen - ELISA ADA (Anti-Drug-Antibody - ELISA Enzyme Activity...

Pharmacokinetics,glp/gcp laboratory,lc/ms-ms,elisa,cro,bioanalysis,analysis of biological samples,rna analysis,hybridization elisa,qpcr,preclinical studies,mirna,biomarker,enzym activity,clinical studies,hplc,ada,protein analysis,small molecules,large molecules,peptide analysis,validation,fda,emea,ich guideline,mrna,oligo,nucleic acid,and pharmaceutical laboratory

Prolytic operates in the Pharmaceutical manufacturing industry.

Prolytic's revenue is 11m - 100m

Prolytic has 11 - 50 employees.